Search research articles
Contact Us
Filters
Showing results (191-200 of 464) with videos related to
Page
of 47
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
November 19, 2021
Anti-Drug Antibody Formation Against Biologic Agents in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
Steven J Bots, Claire E Parker, Johannan F Brandse, et al.
The American Journal of Gastroenterology
|
August 15, 2012
Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT™ registry
Gary R Lichtenstein, Brian G Feagan, Russell D Cohen, et al.
Journal of Crohn'S & Colitis
|
May 5, 2018
The Effects of Ustekinumab on Health-related Quality of Life in Patients With Moderate to Severe Crohn's Disease
Bruce E Sands, Chenglong Han, Christopher Gasink, et al.
Journal of Crohn'S & Colitis
|
September 12, 2018
Incidence of Arthritis/Arthralgia in Inflammatory Bowel Disease with Long-term Vedolizumab Treatment: Post Hoc Analyses of the GEMINI Trials
Brian G Feagan, William J Sandborn, Jean-Frédéric Colombel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 9, 2006
Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry
Gary R Lichtenstein, Brian G Feagan, Russell D Cohen, et al.
Journal of Hypertension
|
June 8, 2013
Simplified therapeutic intervention to control hypertension and hypercholesterolemia: a cluster randomized controlled trial (STITCH2)
George K Dresser, Sigrid A E Nelson, Jeffrey L Mahon, et al.
Journal of Crohn'S & Colitis
|
January 22, 2026
Association between endo-histological outcomes and colonic mucosal transcriptomic profiles in patients with ulcerative colitis receiving filgotinib
Fernando Magro, Gerhard Rogler, Brian G Feagan, et al.
Digestive Diseases and Sciences
|
April 3, 2024
Ozanimod Differentially Impacts Circulating Lymphocyte Subsets in Patients with Moderately to Severely Active Crohn's Disease
Sarah Harris, Brian G Feagan, Stephen Hanauer, et al.
The American Journal of Gastroenterology
|
October 16, 2008
Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trial
Edward V Loftus, Brian G Feagan, Jean-Frédéric Colombel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 31, 2020
Contemporary Risk of Surgery in Patients With Ulcerative Colitis and Crohn's Disease: A Meta-Analysis of Population-Based Cohorts
Lester Tsai, Christopher Ma, Parambir S Dulai, et al.
Page
of 47
Search research articles
Search
Showing results (191-200 of 464) with videos related to
Sort By:
Page
of 47
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
November 19, 2021
Anti-Drug Antibody Formation Against Biologic Agents in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
Steven J Bots, Claire E Parker, Johannan F Brandse, et al.
The American Journal of Gastroenterology
|
August 15, 2012
Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT™ registry
Gary R Lichtenstein, Brian G Feagan, Russell D Cohen, et al.
Journal of Crohn'S & Colitis
|
May 5, 2018
The Effects of Ustekinumab on Health-related Quality of Life in Patients With Moderate to Severe Crohn's Disease
Bruce E Sands, Chenglong Han, Christopher Gasink, et al.
Journal of Crohn'S & Colitis
|
September 12, 2018
Incidence of Arthritis/Arthralgia in Inflammatory Bowel Disease with Long-term Vedolizumab Treatment: Post Hoc Analyses of the GEMINI Trials
Brian G Feagan, William J Sandborn, Jean-Frédéric Colombel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 9, 2006
Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry
Gary R Lichtenstein, Brian G Feagan, Russell D Cohen, et al.
Journal of Hypertension
|
June 8, 2013
Simplified therapeutic intervention to control hypertension and hypercholesterolemia: a cluster randomized controlled trial (STITCH2)
George K Dresser, Sigrid A E Nelson, Jeffrey L Mahon, et al.
Journal of Crohn'S & Colitis
|
January 22, 2026
Association between endo-histological outcomes and colonic mucosal transcriptomic profiles in patients with ulcerative colitis receiving filgotinib
Fernando Magro, Gerhard Rogler, Brian G Feagan, et al.
Digestive Diseases and Sciences
|
April 3, 2024
Ozanimod Differentially Impacts Circulating Lymphocyte Subsets in Patients with Moderately to Severely Active Crohn's Disease
Sarah Harris, Brian G Feagan, Stephen Hanauer, et al.
The American Journal of Gastroenterology
|
October 16, 2008
Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trial
Edward V Loftus, Brian G Feagan, Jean-Frédéric Colombel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 31, 2020
Contemporary Risk of Surgery in Patients With Ulcerative Colitis and Crohn's Disease: A Meta-Analysis of Population-Based Cohorts
Lester Tsai, Christopher Ma, Parambir S Dulai, et al.
Page
of 47